(Q84403784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Regulatory science as a bridge between science and society (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

T Tominaga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Y Asahina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Y Uyama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

T Kondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

29-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

Thalidomide and congenital abnormalities

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.89

7 January 2021

Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.89

7 January 2021

Rosiglitazone: a European regulatory perspective.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.89

7 January 2021

Regulatory action on rosiglitazone by the U.S. Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.89

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21691273%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference